Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2017 | 05-2017 | 02-2017 | 11-2016 | 08-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,533 | 2,789 | 524 | 124 | 93 |
| Receivables | 45 | 57 | 24 | 649 | 131 |
| Inventories | 67 | 128 | 143 | 150 | 135 |
| TOTAL | $2,795 | $3,079 | $804 | $1,067 | $510 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 2 | 2 | 2 |
| Intangibles | 63 | 63 | 63 | 67 | 54 |
| TOTAL | $65 | $65 | $65 | $70 | $56 |
| Total Assets | $2,860 | $3,144 | $869 | $1,137 | $567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 33 | 13 | 26 | 74 | 90 |
| TOTAL | $92 | $40 | $334 | $469 | $434 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 45 | 45 | 45 | 45 |
| Deferred Revenues | 17 | 20 | 25 | 21 | 13 |
| Other Non-Current Liabilities | 238 | 206 | 201 | 183 | 178 |
| TOTAL | $0 | $45 | $45 | $45 | $45 |
| Total Liabilities | $92 | $85 | $379 | $514 | $479 |
| Shareholders' Equity | |||||
| Common Shares | 68 | 67 | 56 | 55 | 51 |
| Retained earnings | -13,170 | -12,483 | -12,144 | -11,696 | -11,301 |
| TOTAL | $3,006 | $3,265 | $691 | $807 | $266 |
| Total Liabilities And Equity | $3,099 | $3,350 | $1,070 | $1,320 | $745 |